Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03216954 · ClinicalTrials.gov registry record · Early Phase 1
Influence of n-Acetylcysteine Maintenance on Alcohol Effects
A Early Phase 1 study, sponsored by William Stoops.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 14
- Enrollment target
NCT03216954 is a Early Phase 1 study that has completed, run by William Stoops. The registered enrollment target is 14 participants.
The verdict
NCT03216954, a Early Phase 1 study, has completed, sponsored by William Stoops.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study will evaluate the behavioral effects of alcohol during placebo and n-acetylcysteine maintenance using sophisticated human laboratory methods.
Interventions
- DRUG Placebos
- DRUG Alcohol
- DRUG N-acetyl cysteine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2017-09-15 |
| Est. Completion | 2020-04-23 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03216954
The ClinicalTrials.gov registry entry for NCT03216954 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is William Stoops, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebos is the first listed.
NCT03216954 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03216954 about?
NCT03216954 is a clinical study titled "Influence of n-Acetylcysteine Maintenance on Alcohol Effects". This study will evaluate the behavioral effects of alcohol during placebo and n-acetylcysteine maintenance using sophisticated human laboratory methods.
What is the current status of trial NCT03216954?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 14 participants. The study started on 2017-09-15. Estimated completion is 2020-04-23.
What interventions are being tested in trial NCT03216954?
The interventions under investigation include: Placebos (DRUG), Alcohol (DRUG), N-acetyl cysteine (DRUG).
Who is sponsoring clinical trial NCT03216954?
This trial is sponsored by William Stoops, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.